📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells. (2023)

First Author: Holmes M

Attributed to: TRAnsFORM: Trial Assessments of Fitness and Outcomes Research in Myeloma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omto.2023.03.002

PubMed Identifier: 37077714

Publication URI: http://europepmc.org/abstract/MED/37077714

Type: Journal Article/Review

Volume: 29

Parent Publication: Molecular therapy oncolytics

ISSN: 2372-7705